CAPITAL MARKETS
We regularly advise issuers, underwriters and sponsors on various types of securities and corporate finance transactions in Hong Kong. These transactions include public listings, back-door listings, private and public offerings, corporate financings, corporate spin-offs, restructurings, rights issues and placings as well as the issue of derivatives, share warrants, convertible notes, bonds and options. The industries we cover include mining, medical and pharmaceutical products, bio-technology, catering, fashion, logistics, telecommunications, manufacturing, wholesale and retail, real estate, securities, investment banking and transportation. Below are some of the substantial transactions our team has advised on:
 
  • advising Crown Landmark Corporation on its unconditional mandatory cash offer to acquire 69.9% of all the issued Shares in VXL Capital Limited (a company listed on the Hong Kong Stock Exchange) in 2014 (Takeover)
  • advising VC Brokerage Limited as Hong Kong legal counsel of the Lead Manager and Bookrunner for the IPO of Ngai Shun Holdings Limited (HK Stock Code: 1246) in 2013
  • advising Value Convergence Holdings Limited (a Hong Kong listed company) on the placing of non-listed warrants in 2013
  • advising VC Brokerage Limited as placing agent on the placing of shares of Asia Energy Logistics Group Limited (a Hong Kong listed company) in 2013
  • advising Sky Earth Limited in the mandatory unconditional general offer for Shenyang Public Utility Holdings Company Limited (a Hong Kong listed company public takeover) in 2012
  • advising VC Brokerage Limited as placing agent on the open offer of China Zenith Chemical Group Limited in 2012
  • advising TLT Lottotainment Group Limited (a Hong Kong listed company) on its top-up and placing transactions in January, April and August 2011
  • advising China Fortune Financial Group Limited (a Hong Kong listed company) on its subscription for exchange note issued by a subsidiary of China Credit Holdings Limited (a Hong Kong listed company) in 2011
  • advising China Grand Pharmaceutical and Healthcare Holdings Limited (a Hong Kong listed company) on its rights issue in 2010
We represent private and listed companies dealing with regulatory matters, including acquisitions, mergers and investigation on contravention of share repurchase rules, insider dealings of futures and securities in relation to the Securities and Futures Commission and the Hong Kong Stock Exchange and inappropriate market behaviours and other contraventions.

 

BACK TO TOP

For further information on this area, please contact: